Indeed, the importance of overcoming this pRb-mediated proliferative barrier during cancer progression is supported by the high incidence of RB1 loss or mutations in human breast cancers with inactivated BRCA1 (refs 51, 52, 53). The gene discussed is RB1; the disease is cancer.